| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 3.55e-07 | 46 | 26 | 4 | GO:0004715 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.10e-06 | 145 | 26 | 5 | GO:0004713 | |
| GeneOntologyMolecularFunction | phospholipase activator activity | 4.06e-04 | 23 | 26 | 2 | GO:0016004 | |
| GeneOntologyMolecularFunction | lipase activator activity | 5.61e-04 | 27 | 26 | 2 | GO:0060229 | |
| GeneOntologyMolecularFunction | ephrin receptor binding | 7.89e-04 | 32 | 26 | 2 | GO:0046875 | |
| GeneOntologyMolecularFunction | phospholipase binding | 7.89e-04 | 32 | 26 | 2 | GO:0043274 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 9.31e-04 | 599 | 26 | 5 | GO:0050839 | |
| GeneOntologyMolecularFunction | protein kinase activity | 9.38e-04 | 600 | 26 | 5 | GO:0004672 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 1.41e-03 | 172 | 26 | 3 | GO:0044325 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 1.97e-03 | 709 | 26 | 5 | GO:0016773 | |
| GeneOntologyMolecularFunction | SH2 domain binding | 2.08e-03 | 52 | 26 | 2 | GO:0042169 | |
| GeneOntologyMolecularFunction | kinase activity | 2.73e-03 | 764 | 26 | 5 | GO:0016301 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 6.49e-03 | 93 | 26 | 2 | GO:0097110 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 6.53e-03 | 938 | 26 | 5 | GO:0016772 | |
| GeneOntologyBiologicalProcess | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 3.55e-06 | 25 | 25 | 3 | GO:0002433 | |
| GeneOntologyBiologicalProcess | Fc-gamma receptor signaling pathway involved in phagocytosis | 3.55e-06 | 25 | 25 | 3 | GO:0038096 | |
| GeneOntologyBiologicalProcess | cellular response to platelet-derived growth factor stimulus | 5.05e-06 | 28 | 25 | 3 | GO:0036120 | |
| GeneOntologyBiologicalProcess | response to platelet-derived growth factor | 6.91e-06 | 31 | 25 | 3 | GO:0036119 | |
| GeneOntologyBiologicalProcess | Fc receptor mediated stimulatory signaling pathway | 1.00e-05 | 35 | 25 | 3 | GO:0002431 | |
| GeneOntologyBiologicalProcess | negative regulation of inflammatory response to antigenic stimulus | 1.19e-05 | 37 | 25 | 3 | GO:0002862 | |
| GeneOntologyBiologicalProcess | Fc-gamma receptor signaling pathway | 1.40e-05 | 39 | 25 | 3 | GO:0038094 | |
| GeneOntologyBiologicalProcess | T cell costimulation | 3.15e-05 | 51 | 25 | 3 | GO:0031295 | |
| GeneOntologyBiologicalProcess | lymphocyte costimulation | 3.54e-05 | 53 | 25 | 3 | GO:0031294 | |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 3.75e-05 | 54 | 25 | 3 | GO:0048013 | |
| GeneOntologyBiologicalProcess | regulation of inflammatory response to antigenic stimulus | 5.40e-05 | 61 | 25 | 3 | GO:0002861 | |
| GeneOntologyBiologicalProcess | adherens junction organization | 5.40e-05 | 61 | 25 | 3 | GO:0034332 | |
| GeneOntologyBiologicalProcess | Fc receptor signaling pathway | 5.67e-05 | 62 | 25 | 3 | GO:0038093 | |
| GeneOntologyBiologicalProcess | immune response-activating cell surface receptor signaling pathway | 6.20e-05 | 359 | 25 | 5 | GO:0002429 | |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 6.84e-05 | 185 | 25 | 4 | GO:0099175 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 8.51e-05 | 71 | 25 | 3 | GO:0043114 | |
| GeneOntologyBiologicalProcess | immune response-regulating cell surface receptor signaling pathway | 9.50e-05 | 393 | 25 | 5 | GO:0002768 | |
| GeneOntologyBiologicalProcess | cell junction organization | 1.16e-04 | 974 | 25 | 7 | GO:0034330 | |
| GeneOntologyBiologicalProcess | leukocyte migration | 1.77e-04 | 449 | 25 | 5 | GO:0050900 | |
| GeneOntologyBiologicalProcess | negative regulation of inflammatory response | 1.84e-04 | 239 | 25 | 4 | GO:0050728 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 2.05e-04 | 246 | 25 | 4 | GO:0045216 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 2.08e-04 | 247 | 25 | 4 | GO:0009612 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | 2.17e-04 | 747 | 25 | 6 | GO:0007169 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | 2.18e-04 | 1077 | 25 | 7 | GO:0098609 | |
| GeneOntologyBiologicalProcess | inflammatory response to antigenic stimulus | 2.57e-04 | 103 | 25 | 3 | GO:0002437 | |
| GeneOntologyBiologicalProcess | cellular response to fluid shear stress | 3.51e-04 | 23 | 25 | 2 | GO:0071498 | |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 3.51e-04 | 23 | 25 | 2 | GO:0002223 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 3.51e-04 | 23 | 25 | 2 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 3.51e-04 | 23 | 25 | 2 | GO:1990840 | |
| GeneOntologyBiologicalProcess | dendritic spine organization | 3.55e-04 | 115 | 25 | 3 | GO:0097061 | |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 3.55e-04 | 115 | 25 | 3 | GO:0150115 | |
| GeneOntologyBiologicalProcess | immune response-activating signaling pathway | 4.63e-04 | 553 | 25 | 5 | GO:0002757 | |
| GeneOntologyBiologicalProcess | neuron projection organization | 4.75e-04 | 127 | 25 | 3 | GO:0106027 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 5.12e-04 | 313 | 25 | 4 | GO:0099173 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | 6.03e-04 | 327 | 25 | 4 | GO:0018108 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | 6.17e-04 | 329 | 25 | 4 | GO:0018212 | |
| GeneOntologyBiologicalProcess | dendrite development | 6.60e-04 | 335 | 25 | 4 | GO:0016358 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 6.88e-04 | 927 | 25 | 6 | GO:0030155 | |
| GeneOntologyBiologicalProcess | T cell chemotaxis | 7.28e-04 | 33 | 25 | 2 | GO:0010818 | |
| GeneOntologyBiologicalProcess | immune response-regulating signaling pathway | 7.51e-04 | 615 | 25 | 5 | GO:0002764 | |
| GeneOntologyBiologicalProcess | activation of immune response | 7.96e-04 | 623 | 25 | 5 | GO:0002253 | |
| GeneOntologyBiologicalProcess | negative regulation of defense response | 8.03e-04 | 353 | 25 | 4 | GO:0031348 | |
| GeneOntologyBiologicalProcess | response to fluid shear stress | 8.19e-04 | 35 | 25 | 2 | GO:0034405 | |
| GeneOntologyBiologicalProcess | cellular response to chemical stress | 1.03e-03 | 377 | 25 | 4 | GO:0062197 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 1.13e-03 | 387 | 25 | 4 | GO:0050807 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 1.22e-03 | 395 | 25 | 4 | GO:0050803 | |
| GeneOntologyBiologicalProcess | cellular response to reactive oxygen species | 1.26e-03 | 178 | 25 | 3 | GO:0034614 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-tyrosine phosphorylation | 1.59e-03 | 193 | 25 | 3 | GO:0050731 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 1.71e-03 | 198 | 25 | 3 | GO:0048813 | |
| GeneOntologyBiologicalProcess | lymphocyte chemotaxis | 1.87e-03 | 53 | 25 | 2 | GO:0048247 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | 1.92e-03 | 447 | 25 | 4 | GO:1903037 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway, planar cell polarity pathway | 2.01e-03 | 55 | 25 | 2 | GO:0060071 | |
| GeneOntologyBiologicalProcess | response to electrical stimulus | 2.09e-03 | 56 | 25 | 2 | GO:0051602 | |
| GeneOntologyBiologicalProcess | regulation of T cell activation | 2.10e-03 | 458 | 25 | 4 | GO:0050863 | |
| GeneOntologyBiologicalProcess | response to food | 2.24e-03 | 58 | 25 | 2 | GO:0032094 | |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 2.31e-03 | 59 | 25 | 2 | GO:0085029 | |
| GeneOntologyBiologicalProcess | antigen receptor-mediated signaling pathway | 2.41e-03 | 223 | 25 | 3 | GO:0050851 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 2.46e-03 | 1186 | 25 | 6 | GO:0007167 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 2.54e-03 | 1194 | 25 | 6 | GO:0000902 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | 2.60e-03 | 486 | 25 | 4 | GO:0007159 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 2.67e-03 | 819 | 25 | 5 | GO:0120039 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine morphogenesis | 2.72e-03 | 64 | 25 | 2 | GO:0061001 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 2.77e-03 | 826 | 25 | 5 | GO:0048858 | |
| GeneOntologyBiologicalProcess | activated T cell proliferation | 2.80e-03 | 65 | 25 | 2 | GO:0050798 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response | 2.93e-03 | 239 | 25 | 3 | GO:0050777 | |
| GeneOntologyBiologicalProcess | hydrogen peroxide metabolic process | 2.97e-03 | 67 | 25 | 2 | GO:0042743 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response | 3.06e-03 | 845 | 25 | 5 | GO:0050778 | |
| GeneOntologyBiologicalProcess | negative regulation of response to external stimulus | 3.07e-03 | 509 | 25 | 4 | GO:0032102 | |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | 3.10e-03 | 1242 | 25 | 6 | GO:0002684 | |
| GeneOntologyBiologicalProcess | vascular endothelial growth factor receptor signaling pathway | 3.15e-03 | 69 | 25 | 2 | GO:0048010 | |
| GeneOntologyBiologicalProcess | response to reactive oxygen species | 3.17e-03 | 246 | 25 | 3 | GO:0000302 | |
| GeneOntologyBiologicalProcess | regulation of inflammatory response | 3.20e-03 | 515 | 25 | 4 | GO:0050727 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | 3.23e-03 | 516 | 25 | 4 | GO:0016055 | |
| GeneOntologyBiologicalProcess | immune effector process | 3.28e-03 | 859 | 25 | 5 | GO:0002252 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 2.26e-05 | 503 | 25 | 6 | GO:0099572 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 4.02e-05 | 56 | 25 | 3 | GO:0099091 | |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum | 5.47e-04 | 29 | 25 | 2 | GO:0097038 | |
| GeneOntologyCellularComponent | actin filament | 6.86e-04 | 146 | 25 | 3 | GO:0005884 | |
| GeneOntologyCellularComponent | postsynapse | 1.05e-03 | 1018 | 25 | 6 | GO:0098794 | |
| GeneOntologyCellularComponent | focal adhesion | 1.60e-03 | 431 | 25 | 4 | GO:0005925 | |
| GeneOntologyCellularComponent | cell-substrate junction | 1.77e-03 | 443 | 25 | 4 | GO:0030055 | |
| GeneOntologyCellularComponent | postsynaptic density | 1.89e-03 | 451 | 25 | 4 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 2.31e-03 | 477 | 25 | 4 | GO:0032279 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 2.49e-03 | 817 | 25 | 5 | GO:0098978 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 3.23e-03 | 523 | 25 | 4 | GO:0098984 | |
| Domain | TyrKc | 1.02e-07 | 88 | 25 | 5 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 1.02e-07 | 88 | 25 | 5 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 1.67e-07 | 97 | 25 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.67e-07 | 97 | 25 | 5 | IPR008266 | |
| Domain | Pkinase_Tyr | 6.91e-07 | 129 | 25 | 5 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 9.66e-07 | 138 | 25 | 5 | IPR001245 | |
| Domain | SH3_1 | 2.26e-06 | 164 | 25 | 5 | PF00018 | |
| Domain | SH3 | 8.69e-06 | 216 | 25 | 5 | PS50002 | |
| Domain | SH3 | 8.69e-06 | 216 | 25 | 5 | SM00326 | |
| Domain | SH2 | 9.34e-06 | 101 | 25 | 4 | PF00017 | |
| Domain | SH3_domain | 9.50e-06 | 220 | 25 | 5 | IPR001452 | |
| Domain | SH2 | 1.31e-05 | 110 | 25 | 4 | SM00252 | |
| Domain | SH2 | 1.36e-05 | 111 | 25 | 4 | PS50001 | |
| Domain | SH2 | 1.41e-05 | 112 | 25 | 4 | IPR000980 | |
| Domain | - | 1.41e-05 | 112 | 25 | 4 | 3.30.505.10 | |
| Domain | Protein_kinase_ATP_BS | 1.27e-04 | 379 | 25 | 5 | IPR017441 | |
| Domain | PROTEIN_KINASE_ATP | 3.10e-04 | 459 | 25 | 5 | PS00107 | |
| Domain | Prot_kinase_dom | 4.15e-04 | 489 | 25 | 5 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 4.31e-04 | 493 | 25 | 5 | PS50011 | |
| Domain | Kinase-like_dom | 6.63e-04 | 542 | 25 | 5 | IPR011009 | |
| Domain | C2-set_2 | 1.37e-03 | 41 | 25 | 2 | PF08205 | |
| Domain | CD80_C2-set | 1.37e-03 | 41 | 25 | 2 | IPR013162 | |
| Domain | Znf_CCCH | 2.72e-03 | 58 | 25 | 2 | IPR000571 | |
| Domain | SPRY | 6.00e-03 | 87 | 25 | 2 | SM00449 | |
| Domain | SPRY | 6.97e-03 | 94 | 25 | 2 | PF00622 | |
| Domain | SPRY_dom | 6.97e-03 | 94 | 25 | 2 | IPR003877 | |
| Domain | B30.2/SPRY | 7.12e-03 | 95 | 25 | 2 | IPR001870 | |
| Domain | B302_SPRY | 7.12e-03 | 95 | 25 | 2 | PS50188 | |
| Domain | IG | 1.81e-02 | 421 | 25 | 3 | SM00409 | |
| Domain | Ig_sub | 1.81e-02 | 421 | 25 | 3 | IPR003599 | |
| Pathway | PID_GLYPICAN_1PATHWAY | 4.06e-08 | 27 | 19 | 4 | M33 | |
| Pathway | PID_EPHRINB_REV_PATHWAY | 6.32e-08 | 30 | 19 | 4 | M257 | |
| Pathway | PID_P38_ALPHA_BETA_PATHWAY | 6.32e-08 | 30 | 19 | 4 | M76 | |
| Pathway | PID_ALPHA_SYNUCLEIN_PATHWAY | 8.27e-08 | 32 | 19 | 4 | M275 | |
| Pathway | PID_EPHA_FWDPATHWAY | 1.07e-07 | 34 | 19 | 4 | M177 | |
| Pathway | PID_AMB2_NEUTROPHILS_PATHWAY | 2.31e-07 | 41 | 19 | 4 | M159 | |
| Pathway | PID_PI3KCI_PATHWAY | 4.42e-07 | 48 | 19 | 4 | M141 | |
| Pathway | REACTOME_PECAM1_INTERACTIONS | 4.53e-07 | 12 | 19 | 3 | MM14835 | |
| Pathway | REACTOME_PECAM1_INTERACTIONS | 4.53e-07 | 12 | 19 | 3 | M11773 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 5.66e-07 | 51 | 19 | 4 | M27311 | |
| Pathway | REACTOME_REGULATION_OF_KIT_SIGNALING | 5.89e-07 | 13 | 19 | 3 | MM14565 | |
| Pathway | PID_PTP1B_PATHWAY | 6.12e-07 | 52 | 19 | 4 | M50 | |
| Pathway | PID_TXA2PATHWAY | 8.28e-07 | 56 | 19 | 4 | M99 | |
| Pathway | REACTOME_REGULATION_OF_KIT_SIGNALING | 1.15e-06 | 16 | 19 | 3 | M537 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 1.61e-06 | 66 | 19 | 4 | MM15925 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 1.67e-06 | 18 | 19 | 3 | MM15023 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 2.33e-06 | 20 | 19 | 3 | M39002 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 2.72e-06 | 21 | 19 | 3 | M5876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 2.72e-06 | 21 | 19 | 3 | MM14996 | |
| Pathway | WP_NRF2ARE_REGULATION | 3.61e-06 | 23 | 19 | 3 | M39761 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 6.11e-06 | 92 | 19 | 4 | M27201 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 7.42e-06 | 29 | 19 | 3 | M27309 | |
| Pathway | PID_CXCR4_PATHWAY | 8.51e-06 | 100 | 19 | 4 | M124 | |
| Pathway | REACTOME_SIGNALING_BY_CSF1_M_CSF_IN_MYELOID_CELLS | 9.11e-06 | 31 | 19 | 3 | M46423 | |
| Pathway | PID_NETRIN_PATHWAY | 1.00e-05 | 32 | 19 | 3 | M108 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 1.10e-05 | 33 | 19 | 3 | M11725 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 1.21e-05 | 34 | 19 | 3 | MM15025 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 1.21e-05 | 34 | 19 | 3 | MM14992 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 1.57e-05 | 37 | 19 | 3 | MM15022 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 1.57e-05 | 37 | 19 | 3 | MM14564 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 2.31e-05 | 42 | 19 | 3 | M27308 | |
| Pathway | PID_PDGFRB_PATHWAY | 2.33e-05 | 129 | 19 | 4 | M186 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 2.48e-05 | 43 | 19 | 3 | M508 | |
| Pathway | WP_IL11_SIGNALING | 2.65e-05 | 44 | 19 | 3 | M39716 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 2.65e-05 | 44 | 19 | 3 | MM14520 | |
| Pathway | WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING | 3.24e-05 | 47 | 19 | 3 | M39380 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 3.46e-05 | 48 | 19 | 3 | MM17214 | |
| Pathway | PID_AJDISS_2PATHWAY | 3.46e-05 | 48 | 19 | 3 | M142 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN | 3.60e-05 | 7 | 19 | 2 | M27912 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 3.91e-05 | 50 | 19 | 3 | M553 | |
| Pathway | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | 6.16e-05 | 9 | 19 | 2 | MM15059 | |
| Pathway | PID_FAK_PATHWAY | 6.43e-05 | 59 | 19 | 3 | M281 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 8.60e-05 | 65 | 19 | 3 | MM14911 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 9.00e-05 | 66 | 19 | 3 | MM14990 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 1.03e-04 | 69 | 19 | 3 | M27108 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 1.12e-04 | 71 | 19 | 3 | MM15947 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 1.22e-04 | 73 | 19 | 3 | M638 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 1.27e-04 | 74 | 19 | 3 | M17386 | |
| Pathway | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | 1.55e-04 | 14 | 19 | 2 | M889 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 1.79e-04 | 15 | 19 | 2 | MM14965 | |
| Pathway | PID_SYNDECAN_3_PATHWAY | 2.31e-04 | 17 | 19 | 2 | M251 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 2.60e-04 | 18 | 19 | 2 | MM15024 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 2.66e-04 | 95 | 19 | 3 | M29842 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 2.90e-04 | 19 | 19 | 2 | M27310 | |
| Pathway | PID_ECADHERIN_KERATINOCYTE_PATHWAY | 3.56e-04 | 21 | 19 | 2 | M184 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 3.56e-04 | 21 | 19 | 2 | MM15633 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 3.91e-04 | 22 | 19 | 2 | M903 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 4.54e-04 | 114 | 19 | 3 | MM14814 | |
| Pathway | WP_GASTRIN_SIGNALING | 4.66e-04 | 115 | 19 | 3 | M39866 | |
| Pathway | REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION | 4.67e-04 | 24 | 19 | 2 | M27803 | |
| Pathway | REACTOME_PARASITE_INFECTION | 4.78e-04 | 116 | 19 | 3 | M29843 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK2_TRKB | 5.07e-04 | 25 | 19 | 2 | M27864 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 7.28e-04 | 134 | 19 | 3 | M29840 | |
| Pathway | REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT | 7.82e-04 | 31 | 19 | 2 | M27805 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 8.79e-04 | 143 | 19 | 3 | M27107 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 1.11e-03 | 155 | 19 | 3 | M522 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.17e-03 | 158 | 19 | 3 | MM14812 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 1.37e-03 | 41 | 19 | 2 | MM15162 | |
| Pathway | WP_IL7_SIGNALING_PATHWAY | 1.50e-03 | 43 | 19 | 2 | MM15864 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 1.57e-03 | 44 | 19 | 2 | M875 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 1.87e-03 | 48 | 19 | 2 | M914 | |
| Pathway | WP_FOCAL_ADHESION | 1.90e-03 | 187 | 19 | 3 | MM15913 | |
| Pathway | WP_IL3_SIGNALING | 1.95e-03 | 49 | 19 | 2 | M39722 | |
| Pathway | WP_TROP2_REGULATORY_SIGNALING | 1.95e-03 | 49 | 19 | 2 | M46458 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 2.11e-03 | 194 | 19 | 3 | M16312 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | 2.18e-03 | 719 | 19 | 5 | MM14540 | |
| Pathway | WP_NETRINUNC5B_SIGNALING | 2.19e-03 | 52 | 19 | 2 | M39782 | |
| Pathway | WP_FOCAL_ADHESION | 2.27e-03 | 199 | 19 | 3 | M39402 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR | 2.28e-03 | 53 | 19 | 2 | M27039 | |
| Pathway | WP_VEGFAVEGFR2_SIGNALING | 2.32e-03 | 431 | 19 | 4 | M39729 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING | 2.81e-03 | 59 | 19 | 2 | M39350 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 2.98e-03 | 219 | 19 | 3 | M29836 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 3.03e-03 | 464 | 19 | 4 | M27547 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.20e-03 | 63 | 19 | 2 | M11187 | |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 3.72e-03 | 68 | 19 | 2 | M39456 | |
| Pathway | KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION | 3.72e-03 | 68 | 19 | 2 | M16848 | |
| Pathway | PID_VEGFR1_2_PATHWAY | 3.83e-03 | 69 | 19 | 2 | M237 | |
| Pathway | PID_CDC42_PATHWAY | 3.94e-03 | 70 | 19 | 2 | M81 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 4.02e-03 | 502 | 19 | 4 | MM14537 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | 4.02e-03 | 828 | 19 | 5 | M1058 | |
| Pathway | WP_AXON_GUIDANCE | 4.16e-03 | 72 | 19 | 2 | M48335 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 4.43e-03 | 252 | 19 | 3 | MM15585 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 4.50e-03 | 75 | 19 | 2 | MM14652 | |
| Pathway | WP_LEPTIN_SIGNALING | 4.62e-03 | 76 | 19 | 2 | M39491 | |
| Pathway | WP_PROLACTIN_SIGNALING | 4.62e-03 | 76 | 19 | 2 | M39601 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 4.88e-03 | 261 | 19 | 3 | MM15676 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 4.95e-03 | 532 | 19 | 4 | M27870 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER | 5.49e-03 | 83 | 19 | 2 | M27163 | |
| Pathway | WP_ACUTE_VIRAL_MYOCARDITIS | 5.75e-03 | 85 | 19 | 2 | M39776 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 5.88e-03 | 86 | 19 | 2 | M601 | |
| Pubmed | Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells. | 3.68e-12 | 6 | 26 | 4 | 2404338 | |
| Pubmed | The SRC-family tyrosine kinase HCK shapes the landscape of SKAP2 interactome. | 2.44e-10 | 14 | 26 | 4 | 29568343 | |
| Pubmed | 3.33e-10 | 15 | 26 | 4 | 25036101 | ||
| Pubmed | Anthrax toxin triggers the activation of src-like kinases to mediate its own uptake. | 3.71e-10 | 3 | 26 | 3 | 20080640 | |
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 20176789 | ||
| Pubmed | Src family kinases are required for integrin but not PDGFR signal transduction. | 3.71e-10 | 3 | 26 | 3 | 10228160 | |
| Pubmed | Localized activation of Src-family protein kinases in the mouse egg. | 3.71e-10 | 3 | 26 | 3 | 17449027 | |
| Pubmed | Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. | 3.71e-10 | 3 | 26 | 3 | 7958873 | |
| Pubmed | 3.71e-10 | 3 | 26 | 3 | 23497302 | ||
| Pubmed | Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. | 3.71e-10 | 3 | 26 | 3 | 10635317 | |
| Pubmed | Src, Fyn and Yes play differential roles in VEGF-mediated endothelial cell events. | 3.71e-10 | 3 | 26 | 3 | 16400523 | |
| Pubmed | Requirement of SRC-family tyrosine kinases in fat accumulation. | 3.71e-10 | 3 | 26 | 3 | 16262245 | |
| Pubmed | 9.44e-10 | 19 | 26 | 4 | 23616926 | ||
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 16585062 | ||
| Pubmed | Src promotes GTPase activity of Ras via tyrosine 32 phosphorylation. | 1.48e-09 | 4 | 26 | 3 | 25157176 | |
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 7521304 | ||
| Pubmed | State and role of SRC family kinases in replication of herpes simplex virus 1. | 1.48e-09 | 4 | 26 | 3 | 16537602 | |
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 14559149 | ||
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 7681396 | ||
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 11245687 | ||
| Pubmed | Autophosphorylation activity and association with Src family kinase of Sky receptor tyrosine kinase. | 1.48e-09 | 4 | 26 | 3 | 7537495 | |
| Pubmed | Endocytosis of collagen by hepatic stellate cells regulates extracellular matrix dynamics. | 1.48e-09 | 4 | 26 | 3 | 25080486 | |
| Pubmed | 1.48e-09 | 4 | 26 | 3 | 19258394 | ||
| Pubmed | Palatal adhesion is dependent on Src family kinases and p38MAPK. | 3.70e-09 | 5 | 26 | 3 | 25354453 | |
| Pubmed | Clustering-induced tyrosine phosphorylation of nephrin by Src family kinases. | 3.70e-09 | 5 | 26 | 3 | 12846735 | |
| Pubmed | 3.70e-09 | 5 | 26 | 3 | 18255094 | ||
| Pubmed | 3.70e-09 | 5 | 26 | 3 | 17623777 | ||
| Pubmed | 3.70e-09 | 5 | 26 | 3 | 12509223 | ||
| Pubmed | 3.70e-09 | 5 | 26 | 3 | 11448999 | ||
| Pubmed | Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. | 3.70e-09 | 5 | 26 | 3 | 18194650 | |
| Pubmed | 3.70e-09 | 5 | 26 | 3 | 10844001 | ||
| Pubmed | Focal adhesion kinase is required for β-catenin-induced mobilization of epidermal stem cells. | 3.70e-09 | 5 | 26 | 3 | 22971575 | |
| Pubmed | 4.33e-09 | 83 | 26 | 5 | 11114734 | ||
| Pubmed | 4.96e-09 | 28 | 26 | 4 | 18067320 | ||
| Pubmed | 7.41e-09 | 6 | 26 | 3 | 19420001 | ||
| Pubmed | 7.41e-09 | 6 | 26 | 3 | 9799234 | ||
| Pubmed | 7.41e-09 | 6 | 26 | 3 | 20606012 | ||
| Pubmed | Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis. | 7.41e-09 | 6 | 26 | 3 | 10861086 | |
| Pubmed | 7.41e-09 | 6 | 26 | 3 | 16723512 | ||
| Pubmed | 7.41e-09 | 6 | 26 | 3 | 1381360 | ||
| Pubmed | 7.41e-09 | 6 | 26 | 3 | 12923167 | ||
| Pubmed | Fyn tyrosine kinase is a critical regulator of disabled-1 during brain development. | 1.30e-08 | 7 | 26 | 3 | 12526739 | |
| Pubmed | 1.30e-08 | 7 | 26 | 3 | 9632142 | ||
| Pubmed | 1.30e-08 | 7 | 26 | 3 | 12538589 | ||
| Pubmed | CMS: an adapter molecule involved in cytoskeletal rearrangements. | 1.30e-08 | 7 | 26 | 3 | 10339567 | |
| Pubmed | Specific interactions of neuronal focal adhesion kinase isoforms with Src kinases and amphiphysin. | 1.30e-08 | 7 | 26 | 3 | 12558988 | |
| Pubmed | 1.30e-08 | 7 | 26 | 3 | 10858437 | ||
| Pubmed | The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation. | 1.30e-08 | 7 | 26 | 3 | 10829062 | |
| Pubmed | QM, a putative tumor suppressor, regulates proto-oncogene c-yes. | 1.30e-08 | 7 | 26 | 3 | 12138090 | |
| Pubmed | Proline-rich sequences that bind to Src homology 3 domains with individual specificities. | 1.30e-08 | 7 | 26 | 3 | 7536925 | |
| Pubmed | Phosphorylation of SOCS1 Inhibits the SOCS1-p53 Tumor Suppressor Axis. | 2.07e-08 | 8 | 26 | 3 | 31101761 | |
| Pubmed | 2.07e-08 | 8 | 26 | 3 | 21829547 | ||
| Pubmed | Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis. | 2.07e-08 | 8 | 26 | 3 | 16921024 | |
| Pubmed | 2.07e-08 | 8 | 26 | 3 | 12640114 | ||
| Pubmed | 2.07e-08 | 8 | 26 | 3 | 15190072 | ||
| Pubmed | Gab2 is involved in differential phosphoinositide 3-kinase signaling by two splice forms of c-Kit. | 3.11e-08 | 9 | 26 | 3 | 18697750 | |
| Pubmed | 4.43e-08 | 10 | 26 | 3 | 11741929 | ||
| Pubmed | 4.43e-08 | 10 | 26 | 3 | 16687575 | ||
| Pubmed | 6.09e-08 | 11 | 26 | 3 | 11312300 | ||
| Pubmed | SRC family kinases are required for limb trajectory selection by spinal motor axons. | 6.09e-08 | 11 | 26 | 3 | 19403835 | |
| Pubmed | 6.09e-08 | 11 | 26 | 3 | 18499741 | ||
| Pubmed | 1.06e-07 | 13 | 26 | 3 | 16162939 | ||
| Pubmed | Integrin signalling regulates YAP and TAZ to control skin homeostasis. | 1.68e-07 | 15 | 26 | 3 | 26989177 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 21901128 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 7507074 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 34105991 | ||
| Pubmed | Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. | 5.37e-07 | 2 | 26 | 2 | 8681387 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 22354875 | ||
| Pubmed | Elevated c-Src and c-Yes expression in malignant skin cancers. | 5.37e-07 | 2 | 26 | 2 | 20796316 | |
| Pubmed | The p60c-src family of protein-tyrosine kinases: structure, regulation, and function. | 5.37e-07 | 2 | 26 | 2 | 1384720 | |
| Pubmed | c-Src but not Fyn promotes proper spindle orientation in early prometaphase. | 5.37e-07 | 2 | 26 | 2 | 22689581 | |
| Pubmed | Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. | 5.37e-07 | 2 | 26 | 2 | 11175854 | |
| Pubmed | The SRC family protein tyrosine kinase p62yes controls polymeric IgA transcytosis in vivo. | 5.37e-07 | 2 | 26 | 2 | 10549294 | |
| Pubmed | Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability. | 5.37e-07 | 2 | 26 | 2 | 15486073 | |
| Pubmed | Specific oncogenic activity of the Src-family tyrosine kinase c-Yes in colon carcinoma cells. | 5.37e-07 | 2 | 26 | 2 | 21390316 | |
| Pubmed | EG-1 interacts with c-Src and activates its signaling pathway. | 5.66e-07 | 22 | 26 | 3 | 16964398 | |
| Pubmed | 8.44e-07 | 25 | 26 | 3 | 16374509 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 11483655 | ||
| Pubmed | Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. | 1.61e-06 | 3 | 26 | 2 | 12089510 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 12695509 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 19690143 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 8983085 | ||
| Pubmed | Raf-1 interacts with Fyn and Src in a non-phosphotyrosine-dependent manner. | 1.61e-06 | 3 | 26 | 2 | 7517401 | |
| Pubmed | Regulation of TRPC6 channel activity by tyrosine phosphorylation. | 1.61e-06 | 3 | 26 | 2 | 14761972 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 8570184 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 15297464 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 16859680 | ||
| Pubmed | Disease-related modifications in tau affect the interaction between Fyn and Tau. | 1.61e-06 | 3 | 26 | 2 | 16115884 | |
| Pubmed | Differential transformation capacity of Src family kinases during the initiation of prostate cancer. | 1.61e-06 | 3 | 26 | 2 | 21464326 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 12932824 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 18579586 | ||
| Pubmed | Specific and redundant roles of Src and Fyn in organizing the cytoskeleton. | 1.61e-06 | 3 | 26 | 2 | 7617039 | |
| Pubmed | Protein tyrosine phosphatase epsilon activates Yes and Fyn in Neu-induced mammary tumor cells. | 1.61e-06 | 3 | 26 | 2 | 14980517 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 25053806 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 7685273 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 11024032 | ||
| Pubmed | Requirements for activation and RAFT localization of the T-lymphocyte kinase Rlk/Txk. | 1.61e-06 | 3 | 26 | 2 | 11353545 | |
| Pubmed | Endocytosis of flotillin-1 and flotillin-2 is regulated by Fyn kinase. | 1.61e-06 | 3 | 26 | 2 | 19258392 | |
| Pubmed | Identification of Grb10 as a direct substrate for members of the Src tyrosine kinase family. | 3.22e-06 | 4 | 26 | 2 | 10871840 | |
| Pubmed | p21rasGAP association with Fyn, Lyn, and Yes in thrombin-activated platelets. | 3.22e-06 | 4 | 26 | 2 | 1544885 | |
| Interaction | PECAM1 interactions | 7.64e-08 | 32 | 26 | 4 | int:PECAM1 | |
| Interaction | EFS interactions | 1.40e-07 | 37 | 26 | 4 | int:EFS | |
| Interaction | SKAP2 interactions | 5.22e-07 | 51 | 26 | 4 | int:SKAP2 | |
| Interaction | ACBD7 interactions | 6.87e-07 | 14 | 26 | 3 | int:ACBD7 | |
| Interaction | TRPV4 interactions | 2.89e-06 | 22 | 26 | 3 | int:TRPV4 | |
| Interaction | NPHS1 interactions | 7.56e-06 | 30 | 26 | 3 | int:NPHS1 | |
| Interaction | PRUNE2 interactions | 9.22e-06 | 32 | 26 | 3 | int:PRUNE2 | |
| Interaction | ANKRD54 interactions | 1.01e-05 | 33 | 26 | 3 | int:ANKRD54 | |
| Interaction | STAP2 interactions | 1.01e-05 | 33 | 26 | 3 | int:STAP2 | |
| Interaction | FLACC1 interactions | 1.11e-05 | 34 | 26 | 3 | int:FLACC1 | |
| Interaction | PRKCH interactions | 1.21e-05 | 35 | 26 | 3 | int:PRKCH | |
| Interaction | DOK2 interactions | 1.41e-05 | 116 | 26 | 4 | int:DOK2 | |
| Interaction | CD36 interactions | 1.69e-05 | 39 | 26 | 3 | int:CD36 | |
| Interaction | KIT interactions | 1.90e-05 | 125 | 26 | 4 | int:KIT | |
| Interaction | LCK interactions | 2.22e-05 | 463 | 26 | 6 | int:LCK | |
| Interaction | PCDHGC3 interactions | 4.53e-05 | 54 | 26 | 3 | int:PCDHGC3 | |
| Interaction | SH3BP1 interactions | 4.78e-05 | 55 | 26 | 3 | int:SH3BP1 | |
| Interaction | CYFIP2 interactions | 5.11e-05 | 323 | 26 | 5 | int:CYFIP2 | |
| Interaction | DOK1 interactions | 5.91e-05 | 59 | 26 | 3 | int:DOK1 | |
| Interaction | PXN interactions | 5.99e-05 | 334 | 26 | 5 | int:PXN | |
| Interaction | IGSF9B interactions | 7.16e-05 | 10 | 26 | 2 | int:IGSF9B | |
| Interaction | PIM3 interactions | 7.19e-05 | 63 | 26 | 3 | int:PIM3 | |
| Interaction | SOCS1 interactions | 7.39e-05 | 177 | 26 | 4 | int:SOCS1 | |
| Interaction | FGD4 interactions | 7.54e-05 | 64 | 26 | 3 | int:FGD4 | |
| Interaction | AIP interactions | 8.24e-05 | 182 | 26 | 4 | int:AIP | |
| Interaction | CDK1 interactions | 8.57e-05 | 590 | 26 | 6 | int:CDK1 | |
| Interaction | ERBB4 interactions | 8.59e-05 | 184 | 26 | 4 | int:ERBB4 | |
| Interaction | GAB3 interactions | 8.74e-05 | 11 | 26 | 2 | int:GAB3 | |
| Interaction | ADAM15 interactions | 9.44e-05 | 69 | 26 | 3 | int:ADAM15 | |
| Interaction | PTPRE interactions | 9.44e-05 | 69 | 26 | 3 | int:PTPRE | |
| Interaction | TNK2 interactions | 1.08e-04 | 195 | 26 | 4 | int:TNK2 | |
| Interaction | PIK3R3 interactions | 1.14e-04 | 198 | 26 | 4 | int:PIK3R3 | |
| Interaction | CBLC interactions | 1.21e-04 | 75 | 26 | 3 | int:CBLC | |
| Interaction | CSF1R interactions | 1.21e-04 | 75 | 26 | 3 | int:CSF1R | |
| Interaction | FBXL22 interactions | 1.24e-04 | 13 | 26 | 2 | int:FBXL22 | |
| Interaction | TBCK interactions | 1.58e-04 | 82 | 26 | 3 | int:TBCK | |
| Interaction | PIK3R1 interactions | 1.61e-04 | 412 | 26 | 5 | int:PIK3R1 | |
| Interaction | TMEM185A interactions | 1.88e-04 | 87 | 26 | 3 | int:TMEM185A | |
| Interaction | GP6 interactions | 1.90e-04 | 16 | 26 | 2 | int:GP6 | |
| Interaction | SLC25A41 interactions | 2.08e-04 | 90 | 26 | 3 | int:SLC25A41 | |
| Interaction | DLG4 interactions | 2.40e-04 | 449 | 26 | 5 | int:DLG4 | |
| Interaction | CTTN interactions | 2.42e-04 | 450 | 26 | 5 | int:CTTN | |
| Interaction | TP53BP2 interactions | 2.42e-04 | 241 | 26 | 4 | int:TP53BP2 | |
| Interaction | HSP90AB3P interactions | 2.67e-04 | 98 | 26 | 3 | int:HSP90AB3P | |
| Interaction | TAMALIN interactions | 2.70e-04 | 19 | 26 | 2 | int:TAMALIN | |
| Interaction | CERS2 interactions | 2.75e-04 | 249 | 26 | 4 | int:CERS2 | |
| Interaction | MAP2 interactions | 3.18e-04 | 104 | 26 | 3 | int:MAP2 | |
| Interaction | FASLG interactions | 3.27e-04 | 105 | 26 | 3 | int:FASLG | |
| Interaction | PEX2 interactions | 3.31e-04 | 21 | 26 | 2 | int:PEX2 | |
| Interaction | CCNL2 interactions | 3.37e-04 | 106 | 26 | 3 | int:CCNL2 | |
| Interaction | DAB1 interactions | 3.46e-04 | 107 | 26 | 3 | int:DAB1 | |
| Interaction | CTNND1 interactions | 3.48e-04 | 265 | 26 | 4 | int:CTNND1 | |
| Interaction | SPRR2A interactions | 3.64e-04 | 22 | 26 | 2 | int:SPRR2A | |
| Interaction | CDH8 interactions | 3.64e-04 | 22 | 26 | 2 | int:CDH8 | |
| Interaction | EPHA3 interactions | 3.86e-04 | 111 | 26 | 3 | int:EPHA3 | |
| Interaction | HOXB5 interactions | 3.96e-04 | 112 | 26 | 3 | int:HOXB5 | |
| Interaction | SPR interactions | 4.06e-04 | 113 | 26 | 3 | int:SPR | |
| Interaction | MED28 interactions | 4.39e-04 | 116 | 26 | 3 | int:MED28 | |
| Interaction | SOS1 interactions | 4.50e-04 | 117 | 26 | 3 | int:SOS1 | |
| Interaction | FLOT2 interactions | 4.58e-04 | 285 | 26 | 4 | int:FLOT2 | |
| Interaction | ITGB4 interactions | 5.46e-04 | 125 | 26 | 3 | int:ITGB4 | |
| Interaction | TRAT1 interactions | 5.51e-04 | 27 | 26 | 2 | int:TRAT1 | |
| Interaction | FYB1 interactions | 7.27e-04 | 31 | 26 | 2 | int:FYB1 | |
| Interaction | SLC14A1 interactions | 8.25e-04 | 33 | 26 | 2 | int:SLC14A1 | |
| Interaction | IL1R1 interactions | 8.75e-04 | 34 | 26 | 2 | int:IL1R1 | |
| Interaction | ARHGAP32 interactions | 9.09e-04 | 149 | 26 | 3 | int:ARHGAP32 | |
| Interaction | KDR interactions | 9.27e-04 | 150 | 26 | 3 | int:KDR | |
| Interaction | FYTTD1 interactions | 1.00e-03 | 154 | 26 | 3 | int:FYTTD1 | |
| Interaction | FAS interactions | 1.01e-03 | 352 | 26 | 4 | int:FAS | |
| Interaction | ANKRD12 interactions | 1.04e-03 | 37 | 26 | 2 | int:ANKRD12 | |
| Interaction | CD46 interactions | 1.04e-03 | 37 | 26 | 2 | int:CD46 | |
| Interaction | MED21 interactions | 1.10e-03 | 159 | 26 | 3 | int:MED21 | |
| Interaction | TYRO3 interactions | 1.12e-03 | 160 | 26 | 3 | int:TYRO3 | |
| Interaction | WBP11 interactions | 1.12e-03 | 160 | 26 | 3 | int:WBP11 | |
| Interaction | GRB10 interactions | 1.14e-03 | 161 | 26 | 3 | int:GRB10 | |
| Interaction | PRRG4 interactions | 1.15e-03 | 39 | 26 | 2 | int:PRRG4 | |
| Interaction | PTPRZ1 interactions | 1.15e-03 | 39 | 26 | 2 | int:PTPRZ1 | |
| Interaction | HSP90AB1 interactions | 1.17e-03 | 960 | 26 | 6 | int:HSP90AB1 | |
| Interaction | PTPN11 interactions | 1.19e-03 | 368 | 26 | 4 | int:PTPN11 | |
| Interaction | SRCIN1 interactions | 1.21e-03 | 40 | 26 | 2 | int:SRCIN1 | |
| Interaction | SRMS interactions | 1.21e-03 | 40 | 26 | 2 | int:SRMS | |
| Interaction | JAK2 interactions | 1.22e-03 | 165 | 26 | 3 | int:JAK2 | |
| Interaction | KHDRBS1 interactions | 1.25e-03 | 373 | 26 | 4 | int:KHDRBS1 | |
| Interaction | JAKMIP1 interactions | 1.40e-03 | 43 | 26 | 2 | int:JAKMIP1 | |
| Interaction | CD244 interactions | 1.40e-03 | 43 | 26 | 2 | int:CD244 | |
| Interaction | DIAPH1 interactions | 1.47e-03 | 176 | 26 | 3 | int:DIAPH1 | |
| Interaction | GAB1 interactions | 1.52e-03 | 178 | 26 | 3 | int:GAB1 | |
| Interaction | RORC interactions | 1.53e-03 | 45 | 26 | 2 | int:RORC | |
| Interaction | FXR1 interactions | 1.56e-03 | 679 | 26 | 5 | int:FXR1 | |
| Interaction | IVNS1ABP interactions | 1.57e-03 | 180 | 26 | 3 | int:IVNS1ABP | |
| Interaction | FLRT1 interactions | 1.60e-03 | 46 | 26 | 2 | int:FLRT1 | |
| Interaction | PRKD1 interactions | 1.67e-03 | 184 | 26 | 3 | int:PRKD1 | |
| Interaction | SH3BP2 interactions | 1.74e-03 | 48 | 26 | 2 | int:SH3BP2 | |
| Interaction | C5orf24 interactions | 1.74e-03 | 48 | 26 | 2 | int:C5orf24 | |
| Interaction | MEOX2 interactions | 1.75e-03 | 697 | 26 | 5 | int:MEOX2 | |
| Interaction | EPHA4 interactions | 1.77e-03 | 188 | 26 | 3 | int:EPHA4 | |
| Interaction | SPHK1 interactions | 1.81e-03 | 49 | 26 | 2 | int:SPHK1 | |
| Interaction | NCSTN interactions | 1.88e-03 | 192 | 26 | 3 | int:NCSTN | |
| Interaction | FRK interactions | 1.89e-03 | 50 | 26 | 2 | int:FRK | |
| Interaction | HCK interactions | 1.91e-03 | 193 | 26 | 3 | int:HCK | |
| Cytoband | 1p34-p33 | 1.85e-06 | 4 | 26 | 2 | 1p34-p33 | |
| Cytoband | 19q13.2 | 3.90e-03 | 164 | 26 | 2 | 19q13.2 | |
| GeneFamily | SH2 domain containing | 4.15e-06 | 101 | 20 | 4 | 741 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 8.84e-04 | 40 | 20 | 2 | 592 | |
| GeneFamily | Immunoglobulin like domain containing | 1.90e-02 | 193 | 20 | 2 | 594 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.61e-06 | 182 | 26 | 4 | d0e3663f7d39f22a3ebd7fde56ab3504773598f4 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-06 | 185 | 26 | 4 | f262b441ea3fe7f69dff33d5f171000371f3a3e5 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-06 | 186 | 26 | 4 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.11e-06 | 188 | 26 | 4 | 0026c9479b30fb39daa91cfa220a88f9c9e65fe7 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-06 | 189 | 26 | 4 | 476226787c8ea0c9834a6f4c99ac7091cc20a455 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-06 | 189 | 26 | 4 | 3fe69bad6427e41b8d2dae450828cc21e9c3b3ad | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-06 | 189 | 26 | 4 | d9c2adbbe3e40eb8d57200b6411533e6685ea0d2 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.65e-06 | 194 | 26 | 4 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.65e-06 | 194 | 26 | 4 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-06 | 199 | 26 | 4 | 07bda4ac8ffdce1a865ebc99e46c2a27925ff7a8 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-06 | 199 | 26 | 4 | f0bf75bfae7b288ecb6801be458b03ebd0108ea7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.25e-06 | 200 | 26 | 4 | 90061284a80d29a4ca6078f578e13d32b8cc80e1 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 167 | 26 | 3 | 9a8e291c082d7c26bab21df77bd36ce927032a70 | |
| ToppCell | facs-Heart-LV-24m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 169 | 26 | 3 | 6a31a940a8474fb087d8fe7193a6974a72e0a014 | |
| ToppCell | facs-Heart-LV-24m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 169 | 26 | 3 | 39d627763abd57e53edb1169832b47cfb3e8c274 | |
| ToppCell | facs-Heart-LV-24m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 169 | 26 | 3 | b85927a256790402e9fc12ebcadd83e4e2afd2ce | |
| ToppCell | facs|World / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 171 | 26 | 3 | 5bcb96ed7fc15548f2dc9cf47482f890640cb39c | |
| ToppCell | facs|World / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-04 | 171 | 26 | 3 | bb71e816dde44fda6af0ad98d979be9f8740fda6 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-04 | 171 | 26 | 3 | b3e6e31dfe3623b960ccf692fdbd236fa4039923 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.32e-04 | 171 | 26 | 3 | 1ae4b6a25bc9c1065cf5d95998ebcc70aee21ab5 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-Memory_B_cells|Lung / Manually curated celltypes from each tissue | 1.34e-04 | 172 | 26 | 3 | 2cb2dc7cfd6db5a98a393b1a84c23abf3d692a53 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-04 | 174 | 26 | 3 | 40bb87d219aafab0357ab0d797efd38085fc0312 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-CD4_TEM|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.38e-04 | 174 | 26 | 3 | d2ea5b55bf03a8013816d073896208f311c3e544 | |
| ToppCell | IPF-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 1.41e-04 | 175 | 26 | 3 | b6d1e40d9339426d778481fd67ab7cbc0f6cb5b2 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.41e-04 | 175 | 26 | 3 | 69ed3c7c45df6bef70f5f2ff003531160bf3b32b | |
| ToppCell | facs-Heart-RV-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 176 | 26 | 3 | fb3d03f64592e1df1d9785d9f2e70938d7ff9ce8 | |
| ToppCell | facs-Heart-RV-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 176 | 26 | 3 | 3270a36fc91a5583646ffeb70bfcbc5af7292aac | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-04 | 176 | 26 | 3 | 77516048aefbe1f48e825052756df0c310c1c486 | |
| ToppCell | facs-Heart-RV-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 176 | 26 | 3 | 99410c121f55adbc7fcc013c8fa8905a45dba76b | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-04 | 176 | 26 | 3 | 96779273b94345250cf53ba671203345b43d9e00 | |
| ToppCell | facs-Heart-LV|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 176 | 26 | 3 | 483e36d9bb7268bf179e69a65e1a0be099035162 | |
| ToppCell | facs-Aorta-Heart-24m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 177 | 26 | 3 | c6b955765aee8a196fcf4f7bb16139c95b76dc4e | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 179 | 26 | 3 | 08cf9986804a6417a9afb19b50c69a3554f71ec6 | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.53e-04 | 180 | 26 | 3 | fcd5d5bf00ee728162b0aac4c81eb78e742cf6f2 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 180 | 26 | 3 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.53e-04 | 180 | 26 | 3 | c2a8f61c806f6f6f47743e9f7c9700705db43386 | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.53e-04 | 180 | 26 | 3 | 178648429686e6d4e6f3aafc350130e819788ecf | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-04 | 180 | 26 | 3 | 30cf3c7ee29694eaccb89bf8053a82037d5c9f1d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 180 | 26 | 3 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 181 | 26 | 3 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 181 | 26 | 3 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 181 | 26 | 3 | 0ba91575fe8851788cebc4cf5a6d76680bf586c5 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 182 | 26 | 3 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 182 | 26 | 3 | ccc313ecc0bfd8e2c6bb83a565b427b2310485ec | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 182 | 26 | 3 | e6a734fb29105093d4cbfc3d0619a825b66da034 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 182 | 26 | 3 | 010a7364da46101cb5068891fd7bc712ea8f13bd | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 182 | 26 | 3 | b9f758961fb4a586ae86fa0b25edb8ce4616d644 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.61e-04 | 183 | 26 | 3 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | facs-Lung-Endomucin-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 183 | 26 | 3 | 3dc6cbe803e5b8c4201faaf2e6445898d71684e6 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 184 | 26 | 3 | df2d42e1eae29fa0a1ed9e389c95b38952b46892 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 184 | 26 | 3 | 1ace70f12b417185bdd46042833f72b3b6815966 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 184 | 26 | 3 | af5eb3650fafc808828eb42f68c0f1e9c278adbb | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 185 | 26 | 3 | a987dbf6adf533c5f8a0a8a465a6c8e67e0ffcc8 | |
| ToppCell | facs-Heart-RV|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 185 | 26 | 3 | 7cf2b0db059605032bfae60cf1b93c4c62608f0c | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-04 | 187 | 26 | 3 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 187 | 26 | 3 | df0279b7e94e26f5541b0e2a0ce56befa96ec8ca | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 1.71e-04 | 187 | 26 | 3 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | facs-Heart-LV-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 187 | 26 | 3 | 1bc338c22d645a854f8d8eb8a064c441121fb673 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-04 | 187 | 26 | 3 | d9d10ed7c905778a29a0dc3ced3eef02a6b1de5c | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-04 | 187 | 26 | 3 | d6765854154557794815514c0aa355bc74b8523e | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD56bright_CD16-|lymph-node_spleen / Manually curated celltypes from each tissue | 1.71e-04 | 187 | 26 | 3 | 9000241566f48e435db9409b7255db68b68f6059 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 188 | 26 | 3 | e901a9bdf00b8e91806f445af66647373bf62661 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 188 | 26 | 3 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | droplet-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.74e-04 | 188 | 26 | 3 | db0652f000d459493321b53239326706eace598c | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 188 | 26 | 3 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 188 | 26 | 3 | 5cf060bb8adaefa9964187195d67993c1248ef47 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 188 | 26 | 3 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 188 | 26 | 3 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 188 | 26 | 3 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-04 | 188 | 26 | 3 | a11b12f1857953bcdbfb5f25e127f2350c39567d | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 188 | 26 | 3 | 8671fdbc4138e6f9559920779c98628ed80f0da3 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 188 | 26 | 3 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 188 | 26 | 3 | 449f9602df3c83b2110eb479a00d428d1b55b423 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-04 | 188 | 26 | 3 | 5d166d9e71632edd059ff0a9f66f8763f259d40a | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 188 | 26 | 3 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 188 | 26 | 3 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.77e-04 | 189 | 26 | 3 | f44ddb6cdbb406b0528a9b0ba3811183ab6d1fc6 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | 30dc1725d43a60017fb12d706f1f85a33de4947e | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | a3f6ebd1622d36d114e42f6e0618d7b2fe8b9a2f | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 189 | 26 | 3 | fccadf8efbef17b7f12291b069c71060a71b04e2 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-04 | 189 | 26 | 3 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | 393ec5954a12d6cf67bb435dcc34ff0b14c81e9f | |
| ToppCell | facs-Trachea-nan-3m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | e3d65417997bdd3f9c312c0977dceb6eca061029 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | d86455cf20769d70d62e2c1dd92cbc93c67aada5 | |
| ToppCell | facs-Trachea-nan-3m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | 5559af03d9d612bb8dcf825e45744a9f8332bac8 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | 1be5067c1e45af7d09c1fd6955952cb9e031a3a0 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | bec57459ad4bab15b2532b57722549fec2e771fb | |
| ToppCell | facs-Trachea-nan-3m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | f60ac60ab9b317a0196f0cbbe520ef7dbd19ac11 | |
| ToppCell | facs-Heart-LV-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | d424d2554595b2304219f7324406b401711af7c2 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | 84036d1257f6b18f47cfc7ac5e6ed6ea3553c235 | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 190 | 26 | 3 | dd89ef1ecea20b2f6fbdc6cea4ca41b28b3ed822 | |
| ToppCell | facs-GAT-Fat-24m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 190 | 26 | 3 | da2fcd4a2cc6e45c8174109d892f1424e39919a1 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 190 | 26 | 3 | c8370c922e0cf0e0c36e02e1ed2b4053ad6a8073 | |
| ToppCell | facs-GAT-Fat-24m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 190 | 26 | 3 | e584eaccbc22aa7f7a4340ed8a2a8b45ddca93f4 | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 190 | 26 | 3 | d3e46cf800a07ca9b01c78192962d223b9785d05 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 190 | 26 | 3 | 89d1d686cc683206534e2157554d7d0df5d53497 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.79e-04 | 190 | 26 | 3 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 190 | 26 | 3 | 5174f91a880f85bb20806023aa68bd4b8ca24ea5 | |
| ToppCell | facs-Lung-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-04 | 190 | 26 | 3 | d55b3ad4d1ec172b042bc08127506c354f87f69d | |
| ToppCell | facs-GAT-Fat-24m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 190 | 26 | 3 | 3395b2ff6ffadf84cdb1b5a37a5b6be05b56c30f | |
| Drug | Dasatinib | 1.58e-07 | 10 | 26 | 3 | DB01254 | |
| Drug | ponatinib | 1.04e-06 | 68 | 26 | 4 | ctd:C545373 | |
| Drug | 1-methyl-1H-indole-2-carboxylic acid | 7.51e-06 | 4 | 26 | 2 | CID000027695 | |
| Drug | polyproline | 1.86e-05 | 295 | 26 | 5 | CID000439587 | |
| Drug | chromium | 3.61e-05 | 339 | 26 | 5 | CID000023976 | |
| Drug | lavendustin A | 4.04e-05 | 171 | 26 | 4 | CID000003894 | |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 6.60e-05 | 194 | 26 | 4 | 3184_DN | |
| Drug | Glibenclamide [10238-21-8]; Down 200; 8uM; MCF7; HT_HG-U133A | 6.73e-05 | 195 | 26 | 4 | 3163_DN | |
| Drug | trichostatin A; Up 200; 0.1uM; HL60; HG-U133A | 6.73e-05 | 195 | 26 | 4 | 364_UP | |
| Drug | Free Radicals | 6.85e-05 | 11 | 26 | 2 | ctd:D005609 | |
| Drug | dasatinib | 6.88e-05 | 70 | 26 | 3 | CID003062316 | |
| Drug | imatinib | 1.11e-04 | 430 | 26 | 5 | CID000005291 | |
| Drug | PD173952 | 1.30e-04 | 15 | 26 | 2 | CID005328733 | |
| Drug | PD173956 | 1.30e-04 | 15 | 26 | 2 | CID005330524 | |
| Drug | EKB-569 | 1.31e-04 | 87 | 26 | 3 | CID006445562 | |
| Drug | AC1L8YWB | 1.49e-04 | 16 | 26 | 2 | CID000435142 | |
| Drug | camonagrel | 1.69e-04 | 17 | 26 | 2 | CID000065892 | |
| Drug | Amifostine | 1.69e-04 | 17 | 26 | 2 | ctd:D004999 | |
| Drug | vandetanib | 1.93e-04 | 99 | 26 | 3 | CID003081361 | |
| Drug | phorbol 12-myristate | 2.07e-04 | 261 | 26 | 4 | CID000107854 | |
| Drug | lariat | 2.29e-04 | 105 | 26 | 3 | CID000165706 | |
| Drug | diphenol | 2.35e-04 | 20 | 26 | 2 | CID000033665 | |
| Drug | hydroxypyridinone | 2.60e-04 | 21 | 26 | 2 | CID000069975 | |
| Drug | rhombic | 2.77e-04 | 112 | 26 | 3 | CID000018879 | |
| Drug | IN1076 | 2.77e-04 | 112 | 26 | 3 | CID000005309 | |
| Drug | NSC119914 | 2.86e-04 | 22 | 26 | 2 | CID000274126 | |
| Drug | Fe(III | 3.13e-04 | 537 | 26 | 5 | CID000023925 | |
| Drug | 6-methoxypurine arabinoside | 3.41e-04 | 24 | 26 | 2 | CID000124757 | |
| Drug | anabaseine | 3.41e-04 | 24 | 26 | 2 | CID000018985 | |
| Drug | 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC | 3.70e-04 | 25 | 26 | 2 | ctd:C432747 | |
| Drug | VX-745 | 3.70e-04 | 25 | 26 | 2 | CID003038525 | |
| Drug | myristate | 3.98e-04 | 310 | 26 | 4 | CID000011005 | |
| Drug | sunitinib | 4.30e-04 | 130 | 26 | 3 | CID005329102 | |
| Drug | G 3012 | 4.49e-04 | 132 | 26 | 3 | CID000120739 | |
| Drug | HU 211 | 4.65e-04 | 28 | 26 | 2 | ctd:C062018 | |
| Drug | selva | 4.65e-04 | 28 | 26 | 2 | CID000010157 | |
| Drug | AHTN | 5.00e-04 | 29 | 26 | 2 | CID000089440 | |
| Drug | AC1NRA8W | 5.00e-04 | 29 | 26 | 2 | CID005287760 | |
| Drug | PCB 47 | 5.71e-04 | 31 | 26 | 2 | CID000017097 | |
| Drug | atremon | 6.48e-04 | 33 | 26 | 2 | CID000002741 | |
| Drug | sodium acetylacetonate | 6.48e-04 | 33 | 26 | 2 | CID000018630 | |
| Drug | Fluorouracil | 6.54e-04 | 1364 | 26 | 7 | ctd:D005472 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; HL60; HT_HG-U133A | 7.86e-04 | 160 | 26 | 3 | 6133_DN | |
| Drug | Cgp77675 | 1.10e-03 | 43 | 26 | 2 | CID005311381 | |
| Drug | fullerene C60 | 1.14e-03 | 1498 | 26 | 7 | ctd:C069837 | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.08e-08 | 30 | 25 | 4 | DOID:9256 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 1.42e-08 | 32 | 25 | 4 | DOID:10155 (implicated_via_orthology) | |
| Disease | kidney disease (implicated_via_orthology) | 3.97e-08 | 41 | 25 | 4 | DOID:557 (implicated_via_orthology) | |
| Disease | carcinoma (implicated_via_orthology) | 2.46e-07 | 64 | 25 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 7.24e-05 | 268 | 25 | 4 | DOID:162 (implicated_via_orthology) | |
| Disease | Colitis | 2.04e-04 | 25 | 25 | 2 | C0009319 | |
| Disease | white matter microstructure measurement | 3.05e-04 | 390 | 25 | 4 | EFO_0005674 | |
| Disease | Alcoholic Intoxication | 3.37e-04 | 32 | 25 | 2 | C0001969 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 6.09e-04 | 43 | 25 | 2 | EFO_0022254 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 8.57e-04 | 51 | 25 | 2 | EFO_0022285 | |
| Disease | family history of Alzheimer’s disease | 1.65e-03 | 71 | 25 | 2 | EFO_0009268 | |
| Disease | mean fractional anisotropy measurement | 2.93e-03 | 95 | 25 | 2 | EFO_0008399 | |
| Disease | Acute Confusional Senile Dementia | 3.18e-03 | 99 | 25 | 2 | C0546126 | |
| Disease | Presenile dementia | 3.18e-03 | 99 | 25 | 2 | C0011265 | |
| Disease | Alzheimer's Disease, Focal Onset | 3.18e-03 | 99 | 25 | 2 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 3.18e-03 | 99 | 25 | 2 | C0750901 | |
| Disease | Alzheimer Disease, Late Onset | 3.18e-03 | 99 | 25 | 2 | C0494463 | |
| Disease | Familial Alzheimer Disease (FAD) | 3.24e-03 | 100 | 25 | 2 | C0276496 | |
| Disease | Alzheimer's Disease | 3.31e-03 | 101 | 25 | 2 | C0002395 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RDPRSEYDRTQPPMQ | 1056 | Q99569 | |
| PMDDRNLYRCGDQPR | 221 | O60909 | |
| RQQENMQRQSRGEPP | 281 | O15372 | |
| REQEAEQMPEYRGRA | 81 | Q13410 | |
| QPQRQRPRESYQMGH | 731 | O14672 | |
| MYPDGRREEPQRQQV | 426 | Q13434 | |
| RADLMQRQGQYDPPP | 41 | Q53FA7 | |
| MRVYQREEVPGCPEA | 141 | Q8IW93 | |
| RLDNRYQPMEPNPRV | 511 | P05164 | |
| MEPAGERFPEQRQVL | 1 | Q9Y5E8 | |
| GNYDIEIRQPPMSER | 641 | Q96MT3 | |
| LEQVERGYRMPCPQD | 476 | P06241 | |
| YPGMSNPEVIRNLER | 436 | P51451 | |
| NPEVIRNLERGYRMP | 441 | P51451 | |
| QPEIQPQEFLNRRYM | 361 | Q6IMN6 | |
| QPRPEDNQSVVRRMQ | 6 | Q8NDH6 | |
| YRNGQRLEVPVEMNP | 186 | P50895 | |
| RQEVPMYTGSEPRQE | 446 | Q96EK7 | |
| RRPLEMEQQQAYRPE | 126 | Q9BUJ2 | |
| PQRGERIPKNMEQYN | 281 | Q14995 | |
| NREVLDQVERGYRMP | 471 | P12931 | |
| GYPERLIQQRHMPER | 456 | Q5HYW2 | |
| LPQGYRMEQPRNCDD | 1066 | P35590 | |
| MQRDVQDPFAPRGQR | 171 | Q5H9L2 | |
| YDAMPRVPDVQDGVR | 396 | Q15149 | |
| GMPQDPPRYQDNREK | 826 | Q9C0D7 | |
| VLEQVERGYRMPCPQ | 481 | P07947 |